CRB Monitor Securities Database Updates
During the week of October 24 - 30, 2022, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.
Summary of the updates for the Week of October 24 - 30, 2022:
Tier |
Total # |
Active / Inactive / Pre-IPO |
Added |
Removed |
Net Change |
Tier 1A |
151 |
127 / 22 / 2 |
+0 | -0 | +0 |
Tier 1B |
724 |
592 / 130 / 2 |
+0 | -0 | +0 |
Tier 2 |
356 |
331 / 22 / 3 |
+0 | -0 | +0 |
Tier 3 |
546 |
517 / 28 / 1 |
+0 | -5 | -5 |
Total Issuances |
1,777 |
1,567 / 202 / 8 |
+0 | -5 | -5 |
Total Issuers (w/o Pre-IPOs) |
1,374 |
- |
+0 | -5 | -5 |
Total Issuers (w/ Pre-IPOs) |
1,384 |
- |
+0 | -5 | -5 |
- Removed 5 Tier 3 Securities:
- -1 = Discarded Business Record from Database: (“Zhejiang Shouxiangu Pharmaceutical Co., Ltd.”)
- Rationale = Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Is a China-based company principally engaged in the production and sales of traditional Chinese medicines. Zhejiang Shouxiangu previously announced a joint venture for a research project to explore the development of products containing cannabis extracts such as cannabidiol. However, it has been over a year since there has been any mention of cannabis in connection with this company. There is no evidence to suggest that this company is still actively engaged in the cannabis industry. As a result, this business no longer qualifies for inclusion.
- -1 = Discarded Business Record from Database: (“Yield10 Bioscience, Inc.”)
- Rationale = Yield10 Bioscience, Inc. is a US-based agricultural bioscience company which was previously involved in a project aimed to increase oil content in plants including cannabis, among others. However, it has been over a year since there has been any mention of cannabis in connection with this company. There is no evidence to suggest that this company is still actively engaged in the cannabis industry. As a result, this business no longer qualifies for inclusion.
- -1 = Discarded Business Record from Database: (“Brenntag AG”)
- Rationale = Brenntag AG is a Germany-based company active in the field of full-line chemical distribution. Brenntag previously announced a collaboration for the development of various nutraceutical products with ingredients including cannabis, among others. However, it has been over a year since there has been any mention of cannabis in connection with this company. There is no evidence to suggest that this company is still actively engaged in the cannabis industry. As a result, this business no longer qualifies for inclusion.
- -1 = Discarded Business Record from Database: (“ViaDerma, Inc.”)
- Rationale = ViaDerma, Inc. is a US-based specialty pharmaceutical company. ViaDerma previously announced that it was in the early development stage of a medical cannabis product containing cannabidiol that could be absorbed through the skin with its proprietary transdermal delivery system. However, it has been over a year since there has been any mention of cannabis in connection with this company. There is no evidence to suggest that this company is still actively engaged in the cannabis industry. As a result, this business no longer qualifies for inclusion.
- -1 = Discarded Business Record from Database: (“NanoVibronix, Inc.”)
- Rationale = NanoVibronix, Inc. is a US-based medical device company which previously announced intent to explore the development of a transdermal delivery device for CBD. However, it has been over a year since there has been any mention of cannabis in connection with this company. There is no evidence to suggest that this company is still actively engaged in the cannabis industry. As a result, this business no longer qualifies for inclusion.
- -1 = Discarded Business Record from Database: (“Zhejiang Shouxiangu Pharmaceutical Co., Ltd.”)
All newly-identified CRBs during the week:
Company Name |
Tier |
Pure-Play | Sector |
Description |
N/A |
N/A | N/A | N/A | N/A |